REGENXBIO Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RGNX | FDMT | IRD | OCGN | NGNE | LXEO | |
|---|---|---|---|---|---|---|
| Market cap | 508.96M | 678.40M | 355.25M | 296.72M | 551.91M | 265.14M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -2.6 | -3.0 | -6.0 | -3.5 | -4.8 | -2.4 |
| Price/book | 5.8 | 1.7 | -27.2 | -16.8 | 2.0 | 1.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −30.98% | +12.45% | +85.38% | −36.59% | +3.45% | −61.64% |
| Today | +1.05% | +2.76% | +8.65% | +17.35% | +3.41% | +3.86% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All RGNX news ›Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on RegenXBio (RGNX), Benitec Biopharma (BNTC) and Vaxcyte (PCVX) with bullish sentiments. H.C. Wainwright analyst Yi Chen reiterated a Buy rating…
REGENXBIO to Host Conference Call on November 5 to Discuss Third Quarter 2026 Financial Results and Operational Highlights
ROCKVILLE, Md., Oct. 29, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 5, at 8:00 a.m. ET to discuss its financial results for the third quarter ended September…
Stocks With Rising Relative Price Strength: Regenxbio
BREAKING: Futures Rise; Musk Warns On Neocloud Rivals Investors.com will undergo scheduled maintenance from 6:00 PM ET to 9:00 PM ET and some features may be unavailable. We apologize for any inconvenience. Regenxbio (RGNX) had its…
REGENXBIO Inc. (RGNX) Discusses Clinical Program Progress and Commercial Outlook in Wet AMD and Rare Diseases - Slideshow
2026-10-22. The following slide deck was published by REGENXBIO Inc. The following slide deck was published by REGENXBIO Inc. in conjunction with this event.
REGENXBIO Eyes Q4 Pivotal Readout for One-Time Wet AMD Gene Therapy
Posted by Tristan Rich on Oct 21st, 2026 The company said it expects to report top-line results later in the fourth quarter from its two pivotal wet AMD studies, ATMOSPHERE and ASCENT, in a planned joint release with partner AbbVie.…
Nabsys Launches RepX™ for Repeat Expansion Analysis Ahead of ASHG 2026
Newswise — PROVIDENCE, R.I., Oct. 15, 2026 -- Nabsys 2.0, LLC ("Nabsys") today announced the release of RepX™, a repeat expansion analysis pipeline available through its Nabsys Navigator™ cloud platform. RepX uses Electronic Genome Mapping…
JPMORGAN CHASE & CO Adds Regenxbio Inc (RGNX) -- Shares Look 54% Undervalued on GF Value
GuruFocus JPMORGAN CHASE & CO Adds Regenxbio Inc (RGNX) -- Shares Look 54% Undervalued on GF Value A Major Institutional Addition to a Clinical-Stage Biotech JPMORGAN CHASE & CO disclosed a significant additio
REGENXBIO: JPMorgan reports 5.3% ownership stake
JPMorgan reports a passive stake above 5% in REGENXBIO (RGNX). Stock Titan - [SCHEDULE 13G] REGENXBIO Inc. Passive Investment Disclosure (>5%) REGENXBIO: JPMorgan reports 5.3% ownership stake REGENXBIO Inc. (RGNX) is the issuer of the…
Certain Pre-Funded Warrants of REGENXBIO Inc. are subject to a Lock-Up Agreement Ending on 15-SEP-2026.
These Pre-Funded Warrants will be under lockup for 61 days starting from 16-JUL-2026 to... Certain Pre-Funded Warrants of REGENXBIO Inc are subject to a Lock-Up Agreement Ending on 15-SEP-2026 T
Regenxbio Inc. Announces Board Changes
REGENXBIO Inc. announced the appointment of Greg Ciongoli to its Board of Directors, effective August 25, 2026. Greg Ciongoli is the Founder and Managing Partner of Adiumentum Capital Management, an... announced the appointment of Greg…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com12
- stocktitan.net3
- gurufocus.com2
- seekingalpha.com2
- investors.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 25 articles, not a forecast.